Third party consultants helping in remediation process: Ipca

0
258

Drug firm today said third party consultants are regularly visiting its three manufacturing plants, which are currently banned from importing products to the US market, to oversee corrective measures being undertaken at the facilities.

“The third party consultants are regularly visiting our manufacturing units which are under USFDA import alert/warning letter and are assisting us in implementing robust remediation measures in a proper and timely manner,” said in a regulatory filing.